Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 87 articles:
HTML format
Text format



Single Articles


    April 2018
  1. BATRA P, Rafie S, Zhang Z, Singh AV, et al
    An Evaluation of the Implementation of Pharmacist-Prescribed Hormonal Contraceptives in California.
    Obstet Gynecol. 2018 Apr 6. doi: 10.1097/AOG.0000000000002572.
    PubMed     Text format     Abstract available


    March 2018
  2. BONNINGTON A, Autry AM
    Abnormal Vaginal Bleeding in Women Desiring Contraception Who Are Taking Anticoagulation Therapy.
    Obstet Gynecol. 2018 Mar 8. doi: 10.1097/AOG.0000000000002518.
    PubMed     Text format     Abstract available


    February 2018
  3. EVANS ML, Espey E, Ogburn T, Zite NB, et al
    Use of Long-Acting Reversible Contraception by Obstetrics and Gynecology Residents: An Examination of Access for All Women.
    Obstet Gynecol. 2018 Feb 5. doi: 10.1097/AOG.0000000000002489.
    PubMed     Text format     Abstract available


    January 2018
  4. STUART GS, Ramesh SS
    Interval Female Sterilization.
    Obstet Gynecol. 2018;131:117-124.
    PubMed     Text format     Abstract available


    December 2017
  5. PAL N, Broaddus RR, Urbauer DL, Balakrishnan N, et al
    Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.
    Obstet Gynecol. 2017 Dec 4. doi: 10.1097/AOG.0000000000002390.
    PubMed     Text format     Abstract available


    November 2017
  6. BIGGS MA, Taylor D, Upadhyay UD
    Role of Insurance Coverage in Contraceptive Use After Abortion.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002361.
    PubMed     Text format     Abstract available


  7. CORTESSIS VK, Barrett M, Brown Wade N, Enebish T, et al
    Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002307.
    PubMed     Text format     Abstract available



  8. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:e251-e269.
    PubMed     Text format     Abstract available



  9. Practice Bulletin No. 186 Summary: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:1173-1175.
    PubMed     Text format     Abstract available


    October 2017
  10. MONIZ MH, Gavin LE, Dalton VK
    Performance Measures for Contraceptive Care: A New Tool to Enhance Access to Contraception.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002314.
    PubMed     Text format     Abstract available


  11. MENKE MN, King WC, White GE, Gosman GG, et al
    Contraception and Conception After Bariatric Surgery.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002323.
    PubMed     Text format     Abstract available


    September 2017
  12. CHEN MJ, Hou MY, Hsia JK, Cansino CD, et al
    Long-Acting Reversible Contraception Initiation With a 2- to 3-Week Compared With a 6-Week Postpartum Visit.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002246.
    PubMed     Text format     Abstract available


  13. MONIZ MH, Spector-Bagdady K, Heisler M, Harris LH, et al
    Inpatient Postpartum Long-Acting Reversible Contraception: Care That Promotes Reproductive Justice.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002262.
    PubMed     Text format     Abstract available


    August 2017
  14. ISEYEMI A, Zhao Q, McNicholas C, Peipert JF, et al
    Socioeconomic Status As a Risk Factor for Unintended Pregnancy in the Contraceptive CHOICE Project.
    Obstet Gynecol. 2017 Aug 4. doi: 10.1097/AOG.0000000000002189.
    PubMed     Text format     Abstract available



  15. Committee Opinion No. 710: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:e74-e80.
    PubMed     Text format     Abstract available



  16. Committee Opinion No. 710 Summary: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:486-487.
    PubMed     Text format     Abstract available


    July 2017
  17. POTTER JE, Coleman-Minahan K, White K, Powers DA, et al
    Contraception After Delivery Among Publicly Insured Women in Texas: Use Compared With Preference.
    Obstet Gynecol. 2017 Jul 7. doi: 10.1097/AOG.0000000000002136.
    PubMed     Text format     Abstract available



  18. Committee Opinion No 707: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:e48-e52.
    PubMed     Text format     Abstract available



  19. Committee Opinion No. 707 Summary: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:251-252.
    PubMed     Text format     Abstract available


    June 2017
  20. KRASHIN JW, Stuart GS, Garrett J, Spector H, et al
    Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002070.
    PubMed     Text format     Abstract available


  21. CARMO LSMP, Braga GC, Ferriani RA, Quintana SM, et al
    Timing of Etonogestrel-Releasing Implants and Growth of Breastfed Infants: A Randomized Controlled Trial.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002092.
    PubMed     Text format     Abstract available


  22. MCHUGH KW, Tucker Edmonds B, Ferries-Rowe E, Haas DM, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2017;129:1136-1137.
    PubMed     Text format    


    May 2017
  23. MONIZ MH, Chang T, Heisler M, Admon L, et al
    Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.
    Obstet Gynecol. 2017 May 5. doi: 10.1097/AOG.0000000000001970.
    PubMed     Text format     Abstract available



  24. Committee Opinion No 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:e142-e149.
    PubMed     Text format     Abstract available



  25. Committee Opinion No. 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:965-966.
    PubMed     Text format     Abstract available


  26. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception.
    Obstet Gynecol. 2017;129:783-785.
    PubMed     Text format    


    April 2017
  27. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception: Speak Up Against the Global Gag Rule.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000002028.
    PubMed     Text format    


  28. ERICKSON AK, Nelson DA, Shaw JG, Loftus PD, et al
    Long-Acting Reversible Contraceptive Placement Among Active-Duty U.S. Army Servicewomen.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000001971.
    PubMed     Text format     Abstract available



  29. Committee Opinion No. 695: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:e109-e116.
    PubMed     Text format     Abstract available



  30. Committee Opinion No 695 Summary: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:775-776.
    PubMed     Text format     Abstract available


    March 2017
  31. DARNEY BG, Aiken AR, Kung S
    Access to Contraception in the Context of Zika: Health System Challenges and Responses.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001914.
    PubMed     Text format     Abstract available


  32. GOYAL V, Canfield C, Aiken AR, Dermish A, et al
    Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001926.
    PubMed     Text format     Abstract available


    February 2017
  33. YANG YT, Sawicki NN
    Pharmacies' Duty to Dispense Emergency Contraception: A Discussion of Religious Liberty.
    Obstet Gynecol. 2017 Feb 6. doi: 10.1097/AOG.0000000000001894.
    PubMed     Text format     Abstract available


    January 2017
  34. WALTER JR, Ghobadi CW, Hayman E, Xu S, et al
    Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance.
    Obstet Gynecol. 2017;129:10-19.
    PubMed     Text format     Abstract available


  35. SCHNATZ PF, Jiang X, Aragaki AK, Nudy M, et al
    Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
    Obstet Gynecol. 2017;129:121-129.
    PubMed     Text format     Abstract available



  36. Clinical Updates in Women's Health Care Summary: Liver Disease: Reproductive Considerations.
    Obstet Gynecol. 2017;129:236.
    PubMed     Text format     Abstract available


    December 2016
  37. HOFLER LG, Cordes S, Cwiak CA, Goedken P, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  38. HIGGINS JA, Sanders JN, Palta M, Turok DK, et al
    Women's Sexual Function, Satisfaction, and Perceptions After Starting Long-Acting Reversible Contraceptives.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  39. SCOCCIA B
    What Is New in Polycystic Ovary Syndrome?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  40. ABBAS DF, Blum J, Ngoc NT, Nga NT, et al
    Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  41. RAYMOND EG, Weaver MA, Louie KS, Tan YL, et al
    Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available



  42. Committee Opinion No 672: Clinical Challenges of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2016;128:e69-77.
    PubMed     Text format     Abstract available



  43. Committee Opinion No 672 Summary Clinical Challenges of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2016;128:674-5.
    PubMed     Text format     Abstract available


    August 2016

  44. Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception.
    Obstet Gynecol. 2016;128:e32-7.
    PubMed     Text format     Abstract available



  45. Committee Opinion No. 670 Summary: Immediate Postpartum Long-Acting Reversible Contraception.
    Obstet Gynecol. 2016;128:422-3.
    PubMed     Text format     Abstract available



  46. Adjunctive Social Media for More Effective Contraceptive Counseling: A Randomized Controlled Trial: Correction.
    Obstet Gynecol. 2016;128:411.
    PubMed     Text format    



  47. Committee Opinion No. 668: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:e20-5.
    PubMed     Text format     Abstract available



  48. Committee Opinion No. 668 Summary: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:418-9.
    PubMed     Text format     Abstract available


    June 2016
  49. RODRIGUEZ MI, Anderson L, Edelman AB
    Prescription of Hormonal Contraception by Pharmacists in Oregon: Implementation of House Bill 2879.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  50. STUART GS
    What Is New in Long-Acting Reversible Contraception?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  51. MOGLIA ML, Nguyen HV, Chyjek K, Chen KT, et al
    Evaluation of Smartphone Menstrual Cycle Tracking Applications Using an Adapted APPLICATIONS Scoring System.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  52. SIMMONS K, Edelman A, Fu R, Jensen J, et al
    A Short Course of Tamoxifen Reduces Unscheduled Bleeding in Etonogestrel Contraceptive Implant Users [24].
    Obstet Gynecol. 2016;127 Suppl 1:9S.
    PubMed     Text format     Abstract available


    February 2016
  53. GALLO MF, Legardy-Williams J, Hylton-Kong T, Rattray C, et al
    Association of Progestin Contraceptive Implant and Weight Gain.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  54. BOOZALIS A, Tutlam NT, Chrisman Robbins C, Peipert JF, et al
    Sexual Desire and Hormonal Contraception.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  55. POTTER JE, Hubert C, Stevenson AJ, Hopkins K, et al
    Barriers to Postpartum Contraception in Texas and Pregnancy Within 2 Years of Delivery.
    Obstet Gynecol. 2016;127:289-96.
    PubMed     Text format     Abstract available


  56. RAYMOND EG, Weaver MA, Tan YL, Louie KS, et al
    Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Obstet Gynecol. 2016;127:306-12.
    PubMed     Text format     Abstract available


    December 2015
  57. D'ALTON ME
    Every Woman, Every Time: Opportunity for Improvement.
    Obstet Gynecol. 2015;126:1133-5.
    PubMed     Text format    


    November 2015
  58. CHAMPALOUX SW, Tepper NK, Curtis KM, Zapata LB, et al
    Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  59. LEMAIRE WJ
    Feminism and the Moral Imperative for Contraception.
    Obstet Gynecol. 2015;126:1108.
    PubMed     Text format    


  60. ESPEY E
    In Reply.
    Obstet Gynecol. 2015;126:1108.
    PubMed     Text format    


  61. CHEN MJ, Creinin MD
    In Reply.
    Obstet Gynecol. 2015;126:1107-8.
    PubMed     Text format    


  62. BLUMENTHAL PD
    Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Obstet Gynecol. 2015;126:1107.
    PubMed     Text format    



  63. ACOG Committee Opinion No. 646: Ethical Considerations for Including Women as Research Participants.
    Obstet Gynecol. 2015;126:e100-7.
    PubMed     Text format     Abstract available


  64. CHEN MJ, Creinin MD
    Removal of a Nonpalpable Etonogestrel Implant With Preprocedure Ultrasonography and Modified Vasectomy Clamp.
    Obstet Gynecol. 2015;126:935-8.
    PubMed     Text format     Abstract available


  65. GILLIAM ML
    Beyond Coercion: Let Us Grapple With Bias.
    Obstet Gynecol. 2015;126:915-6.
    PubMed     Text format    


    October 2015
  66. KAKAIRE O, Byamugisha JK, Tumwesigye NM, Gemzell-Danielsson K, et al
    Intrauterine Contraception Among Women Living With Human Immunodeficiency Virus: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  67. KAVANAUGH ML, Jerman J, Finer LB
    Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009-2012.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available



  68. Committee Opinion No. 642: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy.
    Obstet Gynecol. 2015;126:e44-8.
    PubMed     Text format     Abstract available



  69. Committee Opinion No. 642 Summary: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy.
    Obstet Gynecol. 2015;126:912.
    PubMed     Text format     Abstract available


    September 2015
  70. CHANG K, Merideth MA, Stratton P
    Hormone Use for Therapeutic Amenorrhea and Contraception During Hematopoietic Cell Transplantation.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  71. ABRAHAM M, Zhao Q, Peipert JF
    Young Age, Nulliparity, and Continuation of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available



  72. Practice Bulletin No. 152: Emergency Contraception.
    Obstet Gynecol. 2015;126:e1-e11.
    PubMed     Text format     Abstract available



  73. Practice Bulletin Summary No. 152: Emergency Contraception.
    Obstet Gynecol. 2015;126:685-6.
    PubMed     Text format     Abstract available


    August 2015
  74. ESPEY E
    Feminism and the Moral Imperative for Contraception.
    Obstet Gynecol. 2015;126:396-400.
    PubMed     Text format     Abstract available


  75. LINDLEY KJ, Madden T, Cahill AG, Ludbrook PA, et al
    Contraceptive Use and Unintended Pregnancy in Women With Congenital Heart Disease.
    Obstet Gynecol. 2015;126:363-9.
    PubMed     Text format     Abstract available


  76. BIGGS MA, Harper CC, Brindis CD
    California Family Planning Health Care Providers' Challenges to Same-Day Long-Acting Reversible Contraception Provision.
    Obstet Gynecol. 2015;126:338-45.
    PubMed     Text format     Abstract available


    July 2015
  77. GOLDBERG AB, Fortin JA, Drey EA, Dean G, et al
    Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone Compared With Overnight Osmotic Dilators Alone: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  78. GUIAHI M, McBride M, Sheeder J, Teal S, et al
    Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using a 14-Day Oral Contraceptive Pill Regimen: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  79. DOMINICK SA, McLean MR, Whitcomb BW, Gorman JR, et al
    Contraceptive Practices Among Female Cancer Survivors of Reproductive Age.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  80. HOPKINS MR, Laughlin-Tommaso SK, Wall DJ, Breitkopf DM, et al
    Hysterosalpingography After Radiofrequency Endometrial Ablation and Hysteroscopic Sterilization as a Concomitant Procedure.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  81. DIVASTA AD, Feldman HA, Sadler Gallagher J, Stokes NA, et al
    Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  82. GARIEPY AM, Duffy JY, Xu X
    Cost-Effectiveness of Immediate Compared With Delayed Postpartum Etonogestrel Implant Insertion.
    Obstet Gynecol. 2015;126:47-55.
    PubMed     Text format     Abstract available


  83. CHEN MJ, Creinin MD
    Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Obstet Gynecol. 2015;126:12-21.
    PubMed     Text format     Abstract available


  84. DALTON VK, Wallett S
    The Evolution of Medication Abortion Care: Using Science to Achieve Quality.
    Obstet Gynecol. 2015;126:3-4.
    PubMed     Text format    


    June 2015
  85. WHITE K, Teal SB, Potter JE
    Contraception after delivery and short interpregnancy intervals among women in the United States.
    Obstet Gynecol. 2015;125:1471-7.
    PubMed     Text format     Abstract available


    May 2015
  86. LEKOVICH JP, Amrane S, Pangasa M, Pereira N, et al
    Comparison of human papillomavirus infection and cervical cytology in women using copper-containing and levonorgestrel-containing intrauterine devices.
    Obstet Gynecol. 2015;125:1101-5.
    PubMed     Text format     Abstract available


    March 2015
  87. MCNICHOLAS C, Maddipati R, Zhao Q, Swor E, et al
    Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the u.s. Food and drug administration-approved duration.
    Obstet Gynecol. 2015;125:599-604.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: